Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma

NCT07022223

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
  • Dongyang People's Hospital Dongyang, China
  • Affiliated Hangzhou First People's Hospital Hangzhou, China
  • Zhejiang cancer Hospital Hangzhou, China
View all 18 locations
View Trial Details
Recruiting

Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea

NCT06257394

Conditions
Acute Lymphoblastic Leukemia, Pediatric, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Seoul National University Hospital Seoul, South Korea
  • Severance Hospital Seoul, South Korea
  • Asan Medical Center Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details

Related conditions